Literature DB >> 278

[Biphasic (ulcer-forming and ulcer-preventing) effect of adrenaline in rats].

T Dozaki, K Imai, S Mizukami.   

Abstract

Adrenaline-induced gastric ulceration was studied in rats. Adrenaline in high doses caused gastric ulcer, which was completely blocked by pretreatment with alpha-blockers (phenoxybenzamine, dibenamine), but not by pretreatment with propranolol or atropine, nor by vagotomy, hypophysectomy or adrenalectomy. After successive administration of adrenaline, once daily for 7 days, however, no gastric ulcer was observed. Recovery from the ulcerogenic action of adrenaline was seen after 4 weeks withdrawal. Pretreatment with a small dose of adrenaline inhibited the ulcerogenic action of a high dose of adrenaline. Pretreatment with reserpine, pyrogallol or iproniazid inhibited the action of adrenaline. It is concluded that adrenaline has a biphasic effect on gastric ulceration, the ulcerogenic action is due to its alpha-action and antiulcerogenic effect is due to development of tachyphylaxis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 278

Source DB:  PubMed          Journal:  Nihon Yakurigaku Zasshi        ISSN: 0015-5691


  15 in total

1.  Maturity-onset diabetes of the young (MODY): how many cases are we missing?

Authors:  B M Shields; S Hicks; M H Shepherd; K Colclough; A T Hattersley; S Ellard
Journal:  Diabetologia       Date:  2010-05-25       Impact factor: 10.122

2.  Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene.

Authors:  Christine Bellanné-Chantelot; David Joseph Lévy; Claire Carette; Cécile Saint-Martin; Jean-Pierre Riveline; Etienne Larger; René Valéro; Jean-François Gautier; Yves Reznik; Agnès Sola; Agnès Hartemann; Sandrine Laboureau-Soares; Marie Laloi-Michelin; Pierre Lecomte; Lucy Chaillous; Danièle Dubois-Laforgue; José Timsit
Journal:  J Clin Endocrinol Metab       Date:  2011-06-15       Impact factor: 5.958

Review 3.  The clinical application of non-genetic biomarkers for differential diagnosis of monogenic diabetes.

Authors:  Katharine R Owen; Jan Skupien; Maciej T Malecki
Journal:  Diabetes Res Clin Pract       Date:  2009-12-18       Impact factor: 5.602

Review 4.  Role of molecular genetics in transforming diagnosis of diabetes mellitus.

Authors:  Anders Molven; Pål R Njølstad
Journal:  Expert Rev Mol Diagn       Date:  2011-04       Impact factor: 5.225

5.  Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.

Authors:  Katharine R Owen; Gaya Thanabalasingham; Timothy J James; Fredrik Karpe; Andrew J Farmer; Mark I McCarthy; Anna L Gloyn
Journal:  Diabetes Care       Date:  2010-08-19       Impact factor: 17.152

Review 6.  Hepatic nuclear factor 1-alpha: inflammation, genetics, and atherosclerosis.

Authors:  Angela D Armendariz; Ronald M Krauss
Journal:  Curr Opin Lipidol       Date:  2009-04       Impact factor: 4.776

7.  Genetic cause of hyperglycaemia and response to treatment in diabetes.

Authors:  Ewan R Pearson; Bryan J Starkey; Roy J Powell; Fiona M Gribble; Penny M Clark; Andrew T Hattersley
Journal:  Lancet       Date:  2003-10-18       Impact factor: 79.321

8.  The genetic abnormality in the beta cell determines the response to an oral glucose load.

Authors:  A Stride; M Vaxillaire; T Tuomi; F Barbetti; P R Njølstad; T Hansen; A Costa; I Conget; O Pedersen; O Søvik; R Lorini; L Groop; P Froguel; A T Hattersley
Journal:  Diabetologia       Date:  2002-03       Impact factor: 10.122

9.  Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation.

Authors:  Gordan Lauc; Abdelkader Essafi; Jennifer E Huffman; Caroline Hayward; Ana Knežević; Jayesh J Kattla; Ozren Polašek; Olga Gornik; Veronique Vitart; Jodie L Abrahams; Maja Pučić; Mislav Novokmet; Irma Redžić; Susan Campbell; Sarah H Wild; Fran Borovečki; Wei Wang; Ivana Kolčić; Lina Zgaga; Ulf Gyllensten; James F Wilson; Alan F Wright; Nicholas D Hastie; Harry Campbell; Pauline M Rudd; Igor Rudan
Journal:  PLoS Genet       Date:  2010-12-23       Impact factor: 5.917

10.  High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.

Authors:  Tim J McDonald; Beverley M Shields; Jane Lawry; Katharine R Owen; Anna L Gloyn; Sian Ellard; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2011-06-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.